PPEF1
gene geneOn this page
Also known as PPP7CA
Summary
PPEF1 (protein phosphatase with EF-hand domain 1, HGNC:9243) is a protein-coding gene on chromosome Xp22.13, encoding Serine/threonine-protein phosphatase with EF-hands 1 (O14829). May have a role in the recovery or adaptation response of photoreceptors.
This gene encodes a member of the serine/threonine protein phosphatase with EF-hand motif family. The protein contains a protein phosphatase catalytic domain, and at least two EF-hand calcium-binding motifs in its C terminus. Although its substrate(s) is unknown, the encoded protein has been suggested to play a role in specific sensory neuron function and/or development. This gene shares high sequence similarity with the Drosophila retinal degeneration C (rdgC) gene. Several alternatively spliced transcript variants, each encoding a distinct isoform, have been described.
Source: NCBI Gene 5475 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 149 total — 1 pathogenic
- Druggable target: yes
- MANE Select transcript:
NM_001377996
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:9243 |
| Approved symbol | PPEF1 |
| Name | protein phosphatase with EF-hand domain 1 |
| Location | Xp22.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PPP7CA |
| Ensembl gene | ENSG00000086717 |
| Ensembl biotype | protein_coding |
| OMIM | 300109 |
| Entrez | 5475 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 11 protein_coding, 1 nonsense_mediated_decay
ENST00000349874, ENST00000361511, ENST00000379962, ENST00000470157, ENST00000471570, ENST00000472826, ENST00000496075, ENST00000496616, ENST00000689646, ENST00000692488, ENST00000908182, ENST00000908183
RefSeq mRNA: 14 — MANE Select: NM_001377996
NM_001377986, NM_001377993, NM_001377994, NM_001377995, NM_001377996, NM_001378381, NM_001378382, NM_001389620, NM_001389621, NM_001389623, NM_001389624, NM_006240, NM_152224, NM_152226
CCDS: CCDS14188, CCDS43920, CCDS94563
Canonical transcript exons
ENST00000470157 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001832170 | 18707645 | 18707826 |
| ENSE00003485870 | 18730181 | 18730308 |
| ENSE00003505447 | 18818039 | 18818145 |
| ENSE00003557900 | 18827276 | 18827917 |
| ENSE00003564137 | 18757627 | 18757741 |
| ENSE00003564298 | 18783899 | 18784048 |
| ENSE00003565165 | 18806403 | 18806545 |
| ENSE00003569506 | 18825751 | 18825835 |
| ENSE00003595862 | 18749792 | 18749952 |
| ENSE00003597609 | 18733748 | 18733808 |
| ENSE00003603657 | 18823923 | 18824086 |
| ENSE00003642035 | 18782366 | 18782402 |
| ENSE00003659126 | 18789121 | 18789273 |
| ENSE00003662510 | 18803892 | 18804077 |
| ENSE00003684031 | 18779010 | 18779176 |
| ENSE00003790184 | 18761530 | 18761576 |
Expression profiles
Bgee: expression breadth ubiquitous, 180 present calls, max score 93.11.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4196 / max 69.9440, expressed in 136 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 195692 | 0.2532 | 81 |
| 195689 | 0.1017 | 41 |
| 195693 | 0.0384 | 18 |
| 195690 | 0.0165 | 7 |
| 195691 | 0.0097 | 5 |
Top tissues by expression
292 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 93.11 | gold quality |
| male germ cell | CL:0000015 | 91.47 | gold quality |
| cortical plate | UBERON:0005343 | 85.41 | gold quality |
| secondary oocyte | CL:0000655 | 82.86 | gold quality |
| endothelial cell | CL:0000115 | 82.63 | silver quality |
| dorsal root ganglion | UBERON:0000044 | 82.17 | gold quality |
| oocyte | CL:0000023 | 81.76 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.64 | gold quality |
| left testis | UBERON:0004533 | 81.63 | gold quality |
| right testis | UBERON:0004534 | 81.22 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 80.34 | gold quality |
| testis | UBERON:0000473 | 79.60 | gold quality |
| spinal cord | UBERON:0002240 | 78.86 | gold quality |
| prefrontal cortex | UBERON:0000451 | 75.97 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 75.90 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 73.97 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 73.94 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 73.45 | gold quality |
| frontal cortex | UBERON:0001870 | 72.05 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 71.82 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 71.76 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 71.49 | gold quality |
| neocortex | UBERON:0001950 | 71.18 | gold quality |
| cingulate cortex | UBERON:0003027 | 70.04 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 69.80 | gold quality |
| frontal pole | UBERON:0002795 | 69.61 | silver quality |
| right frontal lobe | UBERON:0002810 | 69.27 | gold quality |
| diaphragm | UBERON:0001103 | 68.88 | gold quality |
| cerebral cortex | UBERON:0000956 | 68.48 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 67.96 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.38 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting PPEF1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-888-3P | 99.53 | 69.77 | 1057 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-12132 | 99.47 | 68.90 | 1341 |
| HSA-MIR-1244 | 99.33 | 68.38 | 832 |
| HSA-MIR-3922-3P | 99.25 | 64.96 | 1136 |
| HSA-MIR-3176 | 99.25 | 64.35 | 954 |
| HSA-MIR-3978 | 99.24 | 68.39 | 2201 |
| HSA-MIR-4426 | 99.17 | 66.74 | 1949 |
| HSA-MIR-4270 | 99.02 | 66.26 | 1987 |
| HSA-MIR-6728-3P | 98.63 | 67.63 | 1534 |
| HSA-MIR-5187-5P | 98.54 | 67.94 | 952 |
| HSA-MIR-4662B | 98.33 | 66.37 | 1163 |
| HSA-MIR-653-3P | 98.31 | 67.71 | 1542 |
| HSA-MIR-4647 | 98.30 | 66.41 | 1139 |
| HSA-MIR-1304-3P | 98.29 | 66.44 | 1207 |
| HSA-MIR-6728-5P | 97.79 | 66.33 | 891 |
| HSA-MIR-490-3P | 97.79 | 65.54 | 606 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-6782-5P | 96.45 | 64.42 | 612 |
| HSA-MIR-3169 | 96.40 | 67.58 | 698 |
| HSA-MIR-10525-3P | 96.32 | 68.04 | 699 |
| HSA-MIR-668-3P | 96.18 | 65.80 | 673 |
| HSA-MIR-6815-5P | 96.05 | 65.55 | 662 |
| HSA-MIR-6865-5P | 96.05 | 65.58 | 675 |
| HSA-MIR-4654 | 95.86 | 65.72 | 751 |
| HSA-MIR-4769-5P | 95.37 | 66.09 | 570 |
Literature-anchored findings (GeneRIF, showing 3)
- PPEF-1V is a 350bp deletion in the nucleotide sequence of PPEF-1 from 128-477bp and a 152-amino-acid N-terminal deletion in the amino acid sequence of PPEF-1. (PMID:22292511)
- Collectively, these data demonstrate that PPEF-1 plays a pivotal role in tumorigenesis of lung cancer cells by reducing PDCD5-mediated genotoxic stress responses. (PMID:28051100)
- The protein phosphatase with EF-hand domain 1 is a calmodulin-binding protein that interacts with proteins involved in sperm capacitation, binding to the zona pellucida, and motility. (PMID:33783058)
Cross-species orthologs
33 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ppef1 | ENSDARG00000020191 |
| mus_musculus | Ppef1 | ENSMUSG00000062168 |
| rattus_norvegicus | Ppef1 | ENSRNOG00000027331 |
| drosophila_melanogaster | PpD5 | FBGN0005778 |
| drosophila_melanogaster | Pp1-Y1 | FBGN0261399 |
| drosophila_melanogaster | rdgC | FBGN0265959 |
| caenorhabditis_elegans | WBGENE00001748 | |
| caenorhabditis_elegans | WBGENE00003969 | |
| caenorhabditis_elegans | WBGENE00007354 | |
| caenorhabditis_elegans | WBGENE00007699 | |
| caenorhabditis_elegans | WBGENE00007700 | |
| caenorhabditis_elegans | WBGENE00007763 | |
| caenorhabditis_elegans | WBGENE00008124 | |
| caenorhabditis_elegans | F22D6.9 | WBGENE00009054 |
| caenorhabditis_elegans | WBGENE00009079 | |
| caenorhabditis_elegans | WBGENE00009101 | |
| caenorhabditis_elegans | WBGENE00009893 | |
| caenorhabditis_elegans | WBGENE00010265 | |
| caenorhabditis_elegans | WBGENE00011133 | |
| caenorhabditis_elegans | WBGENE00012008 | |
| caenorhabditis_elegans | WBGENE00012741 | |
| caenorhabditis_elegans | WBGENE00013476 | |
| caenorhabditis_elegans | WBGENE00014158 | |
| caenorhabditis_elegans | WBGENE00016010 | |
| caenorhabditis_elegans | WBGENE00016081 | |
| caenorhabditis_elegans | F26B1.5 | WBGENE00017817 |
| caenorhabditis_elegans | WBGENE00018359 | |
| caenorhabditis_elegans | WBGENE00018410 | |
| caenorhabditis_elegans | WBGENE00019951 | |
| caenorhabditis_elegans | W03D8.2 | WBGENE00020985 |
| caenorhabditis_elegans | WBGENE00022617 | |
| caenorhabditis_elegans | WBGENE00022710 | |
| caenorhabditis_elegans | Y71G12B.30 | WBGENE00044347 |
Paralogs (12): PPP5C (ENSG00000011485), PPP2CB (ENSG00000104695), PPP3CB (ENSG00000107758), PPP2CA (ENSG00000113575), PPP6C (ENSG00000119414), PPP3CC (ENSG00000120910), PPP3CA (ENSG00000138814), PPP4C (ENSG00000149923), PPEF2 (ENSG00000156194), PPP1CA (ENSG00000172531), PPP1CC (ENSG00000186298), PPP1CB (ENSG00000213639)
Protein
Protein identifiers
Serine/threonine-protein phosphatase with EF-hands 1 — O14829 (reviewed: O14829)
Alternative names: Protein phosphatase with EF calcium-binding domain, Serine/threonine-protein phosphatase 7
All UniProt accessions (6): O14829, A0A8I5KXD3, A0A8I5QKI8, C9JY08, F8WC69, H7C592
UniProt curated annotations — full annotation on UniProt →
Function. May have a role in the recovery or adaptation response of photoreceptors. May have a role in development.
Tissue specificity. Detected in retina and retinal derived Y-79 retinoblastoma cells. Also found in fetal brain.
Activity regulation. Activated by calcium.
Cofactor. Binds 2 manganese ions per subunit.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. May have no functional significance.
Similarity. Belongs to the PPP phosphatase family.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O14829-1 | 1 | yes |
| O14829-2 | 1A | |
| O14829-3 | 1B | |
| O14829-4 | 2 | |
| O14829-5 | 3 |
RefSeq proteins (14): NP_001364915, NP_001364922, NP_001364923, NP_001364924, NP_001364925, NP_001365310, NP_001365311, NP_001376549, NP_001376550, NP_001376552, NP_001376553, NP_006231, NP_689410, NP_689412 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000048 | IQ_motif_EF-hand-BS | Binding_site |
| IPR002048 | EF_hand_dom | Domain |
| IPR004843 | Calcineurin-like_PHP | Domain |
| IPR006186 | Ser/Thr-sp_prot-phosphatase | Domain |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR012008 | Ser/Thr-Pase_EF-hand_contain | Family |
| IPR013235 | PPP_dom | Domain |
| IPR018247 | EF_Hand_1_Ca_BS | Binding_site |
| IPR029052 | Metallo-depent_PP-like | Homologous_superfamily |
| IPR051134 | PPP_phosphatase | Family |
Pfam: PF00149, PF00612, PF08321, PF13499
Catalyzed reactions (Rhea), 2 shown:
- O-phospho-L-seryl-[protein] + H2O = L-seryl-[protein] + phosphate (RHEA:20629)
- O-phospho-L-threonyl-[protein] + H2O = L-threonyl-[protein] + phosphate (RHEA:47004)
UniProt features (30 total): binding site 16, splice variant 5, domain 4, sequence variant 2, chain 1, region of interest 1, active site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O14829-F1 | 80.64 | 0.51 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 234 (proton donor)
Ligand- & substrate-binding residues (16): 201; 233; 285; 403; 579; 581; 583; 590; 619; 621; 623; 625 …
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-2514859 | Inactivation, recovery and regulation of the phototransduction cascade |
MSigDB gene sets: 72 (showing top):
GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOBP_DEPHOSPHORYLATION, GOBP_PROTEIN_DEPHOSPHORYLATION, CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN, GOMF_MANGANESE_ION_BINDING, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS, GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY, GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY, GOMF_IRON_ION_BINDING, chrXp22, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, GOMF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY, GOMF_PHOSPHATASE_ACTIVITY, P53_DN.V2_UP
GO Biological Process (2): protein dephosphorylation (GO:0006470), detection of stimulus involved in sensory perception (GO:0050906)
GO Molecular Function (8): protein serine/threonine phosphatase activity (GO:0004722), iron ion binding (GO:0005506), calcium ion binding (GO:0005509), manganese ion binding (GO:0030145), phosphoprotein phosphatase activity (GO:0004721), protein binding (GO:0005515), hydrolase activity (GO:0016787), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), cytosol (GO:0005829)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| The phototransduction cascade | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transition metal ion binding | 2 |
| dephosphorylation | 1 |
| protein modification process | 1 |
| sensory perception | 1 |
| detection of stimulus | 1 |
| phosphoprotein phosphatase activity | 1 |
| metal ion binding | 1 |
| phosphatase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| binding | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
3193 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PPEF1 | GOLPH3 | Q9H4A6 | 918 |
| PPEF1 | SCML2 | Q9UQR0 | 845 |
| PPEF1 | CDKL5 | O76039 | 738 |
| PPEF1 | RHO | P08100 | 686 |
| PPEF1 | ENDOU | P21128 | 540 |
| PPEF1 | STOML2 | Q9UJZ1 | 527 |
| PPEF1 | CALML5 | Q9NZT1 | 526 |
| PPEF1 | CALML3 | P27482 | 525 |
| PPEF1 | CALML4 | Q96GE6 | 522 |
| PPEF1 | CALML6 | Q8TD86 | 516 |
| PPEF1 | DUSP9 | Q99956 | 482 |
| PPEF1 | CALM1 | P02593 | 469 |
| PPEF1 | MDN1 | Q9NU22 | 448 |
| PPEF1 | PWWP2B | Q6NUJ5 | 440 |
| PPEF1 | ASB12 | Q8WXK4 | 426 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCM2 | KRIT1 | psi-mi:“MI:0914”(association) | 0.960 |
| CALR | PPEF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPEF1 | DLST | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPEF1 | AHCYL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPEF1 | NEK7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPEF1 | CALM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPEF1 | Calm1 | psi-mi:“MI:0915”(physical association) | 0.510 |
| PPEF1 | HSPA8 | psi-mi:“MI:0915”(physical association) | 0.400 |
| PPEF1 | PPEF1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPEF1 | IRS4 | psi-mi:“MI:0914”(association) | 0.350 |
| PPEF1 | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (53): PPEF1 (Two-hybrid), CALM2 (Affinity Capture-MS), HSPA8 (Affinity Capture-MS), IRS4 (Affinity Capture-MS), UBR5 (Affinity Capture-MS), ACSL3 (Affinity Capture-MS), BAG2 (Affinity Capture-MS), GLUD1 (Affinity Capture-MS), ATP2A2 (Affinity Capture-MS), DNAJA1 (Affinity Capture-MS), TUBB4B (Affinity Capture-MS), TUBB2A (Affinity Capture-MS), HERC1 (Affinity Capture-MS), NTPCR (Affinity Capture-MS), TUBB2B (Affinity Capture-MS)
ESM2 similar proteins: A0A4X1T4U3, A4IFD0, F1QWA8, O02697, O14829, O14830, O14936, O35099, O35385, O35655, O60308, O70589, O76074, O77746, P26045, P33402, P48736, Q21029, Q28156, Q32M07, Q3SWT6, Q3USB7, Q3UYK3, Q3V3E1, Q4R3W4, Q502L7, Q5M7G4, Q5VRN0, Q62688, Q62915, Q68FP8, Q6AZT7, Q6P618, Q6ZT07, Q8BGG7, Q8BTI9, Q8CG03, Q8TEU7, Q8TF42, Q8VDY4
Diamond homologs: A0CNL9, A0DJ90, G5EBX9, G5EGK8, O04857, O14829, O14830, O15757, O35385, O35655, O43049, O76932, O82733, O82734, P11493, P11611, P11612, P12982, P13681, P20654, P22198, P23594, P23595, P23733, P23734, P23777, P23880, P30366, P32598, P33329, P36873, P36874, P40421, P48461, P48462, P48463, P48480, P48481, P48482, P48483
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| PPEF1 | “down-regulates quantity by destabilization” | PDCD5 | dephosphorylation |
Disease & clinical
Clinical variants and AI predictions
ClinVar
149 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 25 |
| Likely benign | 8 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 833472 | NC_000023.10:g.(?18660114)(19377781_?)del | Pathogenic |
SpliceAI
3091 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:18727584:C:G | donor_gain | 1.0000 |
| X:18730162:A:AG | acceptor_gain | 1.0000 |
| X:18730163:T:G | acceptor_gain | 1.0000 |
| X:18730164:A:AG | acceptor_gain | 1.0000 |
| X:18730164:ATTCT:A | acceptor_gain | 1.0000 |
| X:18730168:T:TA | acceptor_gain | 1.0000 |
| X:18730170:T:TA | acceptor_gain | 1.0000 |
| X:18730171:G:A | acceptor_gain | 1.0000 |
| X:18730180:G:GA | acceptor_gain | 1.0000 |
| X:18730180:GCA:G | acceptor_gain | 1.0000 |
| X:18730304:TGCAG:T | donor_loss | 1.0000 |
| X:18730306:CAGGT:C | donor_loss | 1.0000 |
| X:18730307:AGG:A | donor_loss | 1.0000 |
| X:18730308:GGT:G | donor_loss | 1.0000 |
| X:18730309:GT:G | donor_loss | 1.0000 |
| X:18730310:T:A | donor_loss | 1.0000 |
| X:18733746:A:AG | acceptor_gain | 1.0000 |
| X:18733747:G:GA | acceptor_gain | 1.0000 |
| X:18733747:GTT:G | acceptor_gain | 1.0000 |
| X:18747341:G:GT | donor_gain | 1.0000 |
| X:18749790:A:AG | acceptor_gain | 1.0000 |
| X:18749791:G:GA | acceptor_gain | 1.0000 |
| X:18749791:GAA:G | acceptor_gain | 1.0000 |
| X:18749791:GAAT:G | acceptor_gain | 1.0000 |
| X:18749952:GGTA:G | donor_loss | 1.0000 |
| X:18749953:G:GG | donor_gain | 1.0000 |
| X:18749954:T:A | donor_loss | 1.0000 |
| X:18779005:CACA:C | acceptor_loss | 1.0000 |
| X:18779007:CA:C | acceptor_loss | 1.0000 |
| X:18779008:A:AG | acceptor_gain | 1.0000 |
AlphaMissense
774 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:18827308:T:A | W595R | 0.987 |
| X:18827308:T:C | W595R | 0.987 |
| X:18825808:T:C | F575L | 0.986 |
| X:18825810:T:A | F575L | 0.986 |
| X:18825810:T:G | F575L | 0.986 |
| X:18827417:T:C | F631S | 0.984 |
| X:18818107:T:A | L488H | 0.983 |
| X:18818119:T:C | F492S | 0.981 |
| X:18827297:T:C | F591S | 0.979 |
| X:18818107:T:G | L488R | 0.978 |
| X:18825797:T:C | L571P | 0.977 |
| X:18825832:T:C | S583P | 0.977 |
| X:18827414:A:T | E630V | 0.977 |
| X:18827282:T:A | I586N | 0.974 |
| X:18827428:T:C | F635L | 0.968 |
| X:18827430:C:A | F635L | 0.968 |
| X:18827430:C:G | F635L | 0.968 |
| X:18827282:T:G | I586S | 0.967 |
| X:18827382:C:A | D619E | 0.964 |
| X:18827382:C:G | D619E | 0.964 |
| X:18827402:T:A | I626N | 0.963 |
| X:18827282:T:C | I586T | 0.960 |
| X:18827387:A:T | N621I | 0.960 |
| X:18825806:T:A | I574K | 0.958 |
| X:18825809:T:C | F575S | 0.958 |
| X:18827380:G:C | D619H | 0.958 |
| X:18825820:G:C | D579H | 0.956 |
| X:18825822:C:A | D579E | 0.956 |
| X:18825822:C:G | D579E | 0.956 |
| X:18827425:G:C | A634P | 0.953 |
dbSNP variants (sampled 300 via entrez): RS1000015083 (X:18819184 A>T), RS1000017683 (X:18688292 C>T), RS1000032113 (X:18677638 A>T), RS1000065896 (X:18794767 T>A), RS1000086467 (X:18713589 G>A), RS1000086852 (X:18819643 G>A,C), RS1000095299 (X:18677031 C>A), RS1000115363 (X:18733159 T>G), RS1000130846 (X:18724602 C>T), RS1000143502 (X:18712043 C>T), RS1000146341 (X:18677324 C>G), RS1000175438 (X:18724248 C>G), RS1000214523 (X:18778828 T>G), RS1000241149 (X:18765502 A>G), RS1000269440 (X:18786848 T>A)
Disease associations
OMIM: gene MIM:300109 | disease phenotypes: MIM:312170
GenCC curated gene-disease
Mondo (1): pyruvate dehydrogenase E1-alpha deficiency (MONDO:0010717)
Orphanet (1): Pyruvate dehydrogenase E1-alpha deficiency (Orphanet:79243)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C564071 | Pyruvate Dehydrogenase E1 Alpha Deficiency (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL5465274 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation, increases mutagenesis | 2 |
| Thapsigargin | decreases expression, increases expression | 2 |
| bufotalin | decreases expression | 1 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| entinostat | increases expression | 1 |
| abrine | increases expression | 1 |
| licochalcone B | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Tunicamycin | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Permethrin | increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5326483 | Binding | Inhibition of PP7 (unknown origin) phosphatase domain | Dual function of protein phosphatase 5 (PPP5C): An emerging therapeutic target for drug discovery. — Eur J Med Chem |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TF28 | HAP1 PPEF1 (-) | Cancer cell line | Male |
Clinical trials (associated diseases)
1 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT05257005 | Not specified | UNKNOWN | Natural History Study of Pyruvate Dehydrogenase Deficiency |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): pyruvate dehydrogenase E1-alpha deficiency